Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Bioadaptives (BDPT) Other Operating Expenses (2019 - 2025)

Bioadaptives' Other Operating Expenses history spans 7 years, with the latest figure at $27438.0 for Q4 2025.

  • Quarterly results put Other Operating Expenses at $27438.0 for Q4 2025, down 65.14% from a year ago — trailing twelve months through Dec 2025 was $234162.0 (down 13.53% YoY), and the annual figure for FY2025 was $234162.0, down 13.53%.
  • Other Operating Expenses for Q4 2025 was $27438.0 at Bioadaptives, up from $18569.0 in the prior quarter.
  • In the past five years, Other Operating Expenses ranged from a high of $207758.0 in Q1 2021 to a low of $8919.0 in Q1 2023.
  • The 5-year median for Other Operating Expenses is $60545.0 (2022), against an average of $59803.2.
  • The sharpest move saw Other Operating Expenses soared 662.84% in 2021, then tumbled 87.44% in 2023.
  • Year by year, Other Operating Expenses stood at $63384.0 in 2021, then plummeted by 82.79% to $10911.0 in 2022, then soared by 113.21% to $23263.0 in 2023, then soared by 238.38% to $78718.0 in 2024, then tumbled by 65.14% to $27438.0 in 2025.
  • According to Business Quant data, Other Operating Expenses over the past three periods came in at $27438.0, $18569.0, and $82390.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.